Imipenem and Cilastatin Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-01-08 · last update 2026-01-08
Manufacturers: Merck Sharp & Dohme Corp.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Primaxin, Injection, 500mg (NDC 0006-3516-59) | Merck Sharp & Dohme Corp. | To Be Discontinued | — | To be discontinued approximately 11/30/2026 | Posted 01/08/2026 Updated 01/08/2026 Discontinued 01/08/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)